Testosterone inhibits estrogen/progestogen-induced breast cell proliferation in postmenopausal women

Menopause

Volumn 14, Issue 2, 2007, Pages 183-190

  Hofling, Marie ^a   Hirschberg, Angelica Lindén ^a   Skoog, Lambert ^a   Tani, Edneia ^a   Hägerström, Torsten ^a   Von Schoultz, Bo ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Breast cell proliferation; Hormone therapy; Testosterone treatment

Indexed keywords

ESTRADIOL PLUS NORETHISTERONE ACETATE; MONOCLONAL ANTIBODY KI 67; PLACEBO; TESTOSTERONE;

ADULT; AGED; ARTICLE; ASPIRATION BIOPSY; BREAST CELL; CELL PROLIFERATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; EPITHELIUM CELL; ESTROGEN THERAPY; FEMALE; HORMONE SUBSTITUTION; HUMAN; IMMUNOHISTOCHEMISTRY; OUTCOME ASSESSMENT; POSTMENOPAUSE; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; STROMA CELL; TREATMENT DURATION; TREATMENT OUTCOME;

ADMINISTRATION, CUTANEOUS; AGED; BIOPSY, NEEDLE; BREAST; BREAST NEOPLASMS; CELL PROLIFERATION; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INSULIN-LIKE GROWTH FACTOR I; MIDDLE AGED; NORETHINDRONE; POSTMENOPAUSE; SEX HORMONE-BINDING GLOBULIN; TESTOSTERONE; TREATMENT OUTCOME;

EID: 34247643957     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.gme.0000232033.92411.51     Document Type: Article

References (38)

1. Chlebowski RT, Hendrix SL, Langer RD, et al. Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative randomized trial. JAMA 2003;289:3243-3253.
2. Beral V. Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 2003;362:419-427.
3. Preston-Martin S, Pike MC, Ross RK, Jones PA, Henderson BE. Increased cell division as a cause of human cancer. Cancer Res 1990;50:7415-7421.
4. Conner P, Söderqvist G, Skoog L, et al. Breast cell proliferation in postmenopausal women during HRT evaluated through fine needle aspiration cytology. Breast Cancer Res Treat 2003;78:159-165.
5. Conner P, Christow A, Kersemaekers W, et al. A comparative study of breast cell proliferation during hormone replacement therapy: effects of tibolone and continuous combined estrogen-progestogen treatment. Climacteric 2004;7:50-58.
6. Birrell SN, Bentel JM, Hickey TE, et al. Androgens induce divergent proliferative responses in human breast cancer cell lines. J Steroid Biochem Mol Biol 1995;52:459-467.
7. Jayo MJ, Register TC, Hughes CL, et al. Effects of an oral contraceptive combination with or without androgen on mammary tissues: a study in rats. J Soc Gynecol Investig 2000;7:257-265.
8. Dimitrakakis C, Zhou J, Wang J, et al. A physiological role for testosterone in limiting estrogenic stimulation of the breast. Menopause 2003;10:292-298.
9. Isaksson E, von Schoultz E, Odlind V, et al. Effects of oral contraceptives on breast epithelial proliferation. Breast Cancer Res Treat 2001;65:163-169.
10. Mazer NA, Shifren JL. Transdermal testosterone for women: a new physiological approach for androgen therapy. Obstet Gynecol Surv 2003;58:489-500.
11. Franzen S, Zajicek J. Aspiration biopsy in diagnosis of palpable lesions of the breast: critical review of 3479 consecutive biopsies. Acta Radiol Ther Phys Biol 1968;7:241-262.
12. Skoog L, Humla S, Isaksson S, Tani E. Immunocytochemical analysis of receptors for estrogen and progesterone in fine-needle aspirates from human breast carcinomas. Diagn Cytopathol 1990;6:95-98.
13. Gerdes J, Li L, Schlueter C, et al. Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67. Am J Pathol 1991;138:867-873.
14. Herrmann H, Aebi U. Intermediate filaments and their associates: multi-talented structural elements specifying cytoarchitecture and cytodynamics. Curr Opin Cell Biol 2000;12:79-90.
15. Södergå rd R, Bäckström T, Shanbhag V, Carstensen H. Calculation of free and bound fractions of testosterone and estradiol-17β to human plasma proteins at body temperature. J Steroid Biochem 1982;16:801-810.
16. Löfgren L, Skoog L, von Schoultz E, et al. Hormone receptor status in breast cancer - a comparison between surgical specimens and fine needle aspiration biopsies. Cytopathology 2003;14:136-142.
17. Söderqvist G. Effects of sex steroids on proliferation in normal mammary tissue. Ann Med 1998;30:511-524.
18. Donegan W. Diagnosis. In: Donegan WL, Spratt JS, eds. Cancer of the Breast. Philadelphia, Pa: WB Saunders, 1995:157-285.
19. Cline JM, Söderqvist G, von Schoultz B, Skoog L. Regional distribution of proliferating cells and hormone receptors in the mammary gland of surgically postmenopausal macaques. Gynecol Obstet Invest 1997;44:41-46.
20. Lundström E, Söderqvist G, Svane G, et al. Digitized assessment of mammographic breast density in patients who received low-dose intrauterine levonorgestrel in continuous combination with oral estradiol valerate: a pilot study. Fertil Steril 2006;85:989-995.
21. Lundström E, Wilczek B, von Palffy Z, Söderqvist G, von Schoultz B. Mammographic breast density during hormone replacement therapy: differences according to treatment. Am J Obstet Gynecol 1999;181:348-352.
22. Gammon MD, Thompson WD. Polycystic ovaries and the risk of breast cancer. Am J Epidemiol 1991;134:818-824.
23. Lobaccaro JM, Lumbroso S, Belon C, et al. Male breast cancer and the androgen receptor gene. Nat Genet 1993;5:109-110.
24. Haiman CA, Brown M, Hankinson SE, et al. The androgen receptor CAG repeat polymorphism and risk of breast cancer in the Nurses' Health Study. Cancer Res 2002;62:1045-1049.
25. Shekhar MP, Pauley R, Heppner G. Host microenvironment in breast cancer development: extracellular matrix-stromal cell contribution to neoplastic phenotype of epithelial cells in the breast. Breast Cancer Res 2003;5:130-135.
26. Beato M, Klug J. Steroid hormone receptors: an update. Hum Reprod Update 2000;6:225-236.
27. Haslam SZ, Counterman LJ, Nummy KA. EGF receptor regulation in normal mouse mammary gland. J Cell Physiol 1992;152:553-557.
28. Couse J, Lindzey J, Grandien K, Gustafsson JA, Korach K. Tissue distribution and quantitative analysis of estrogen receptor-α (ER-α) and estrogen receptor-β (ER-β) messenger ribonucleic acid in the wild-type and ER-α-knockout mouse. Endocrinology 1997;138:4613-4621.
29. Daniel CW, Silberstein GB, Strickland B. Direct action of 17β-estradiol on mouse mammary ducts analyzed by sustained release implants and steroid autoradiography. Cancer Res 1987;47:6052-6057.
30. Zeps N, Bentel J, Papadimitriou J, D'Antuono M, Dawkins H. Estrogen receptor-negative epithelial cells in mouse mammary gland development and growth. Differentiation 1998;62:221-226.
31. Imagawa W, Pedchenko VK, Helber J, Zhang H. Hormone/ growth factor interactions mediating epithelial/stromal communication in mammary gland development and carcinogenesis. J Steroid Biochem Mol Biol 2002;80:213-230.
32. Cunha GR, Young P, Hom YK, Cooke PS, Taylor JA, Lubahn DB. Elucidation of a role for stromal steroid hormone receptors in mammary gland growth and development using tissue recombinants. J Mammary Gland Biol Neoplasia 1997;2:393-402.
33. Cooke P, Buchanan D, Lubahn D, Cunha G. Mechanism of estrogen action: lessons from the estrogen receptor-α knockout mouse. Biol Reprod 1998;59:470-475.
34. Kollara A, Kahn HJ, Marks A, Brown TJ. Loss of androgen receptor associated protein 70 (ARA70) expression in a subset of HER2-positive breast cancers. Breast Cancer Res Treat 2001;67:245-253.
35. Toth-Fejel S, Cheek J, Calhoun K, Muller P, Pommier R. Estrogen and androgen receptors as comediators of breast cancer cell proliferation: providing a new therapeutic tool. Arch Surg 2004;139:50-54.
36. Somboonporn W, Davis S. Postmenopausal testosterone therapy and breast cancer risk. Maturitas 2004;49:267-275.
37. Conde I, Alfaro JM, Fraile B, Ruiz A, Paniagua R, Arenas MI. DAX-1 expression in human breast cancer: comparison with estrogen receptors ER-α, ER-β and androgen receptor status. Breast Cancer Res 2004;6:140-148.
38. Burak WE Jr, Quinn AL, Farrar WB, Brueggemeier RW. Androgens influence estrogen-induced responses in human breast carcinoma cells through cytochrome P450 aromatase. Breast Cancer Res Treat 1997;44:57-64.